Interstitial lung diseases as sarcoidosis and idiopathic pulmonary fibrosis are rare diseases. Although all the techniques for phenotyping-genotyping-correlation studies are available, no single center can perform these studies due to the low prevalence of the named disorders. In particular, rare phenotypes of these diseases cannot be collected at one center in sufficient number. In view of the fact that sufficiently large cohorts could be recruited if the major European centers would cooperate the ERS research seminar "Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases" was held to set the stage for future cooperative studies.
Exploration of the Genetic Etiology of Complex Inflammatory Disorders: The Example of Crohn’s Disease S. Schreiber (Kiel, Germany)
| |
Searching for suceptibility genes: Association studies M. Luisetti (Pavia, Italy)
| |
Searching for suceptibility genes: Family studies M. Schürmann (Lübeck, Germany)
| |
Sarcoidosis and chronic beryllium disease: Differences in genotype and phenotype? C. Saltini (Rome, Italy)
| |
Disease modifying genes: The cystic fibrosis lesson A. Clement (Paris, France)
| |
Genes expression and histological phenotype H. Popper (Graz, Austria)
| |
Pedicting sarcoid phenotypes R. M. Du Bois (London, United Kingdom)
| |
Phenotyping of the inflammatory sarcoid response N. Mc Elvaney (Dublin 9, United Kingdom)
| |
Clinical and laboratory parameters to categorise Sarcoidosis M. Drent (Maastricht, The Netherlands)
| |
Web-based documentation of phenotypes B. Grimbacher (Freiburg, Germany)
| |
Clinical categorisation of idiopathic interstitial pneumonias J. Grutters (Odijk, The Netherlands)
| |
Idiopathic interstitial pneumonias - where is inflammation of relevance? E. K. Verbeken (Leuven, Belgium)
| |
Disease-modifying genes in IPF A. Xaubet Mir (Barcelona, Spain)
| |
Serum markers of IPF M. Thomeer (Leuven, Belgium)
| |